カテゴリー： GlobalInfoResearch, 世界

放射線誘発骨髄抑制治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Radiation-Induced Myelosuppression Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9103354）・商品コード：GIR9103354
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月26日（※2024年版があります。お問い合わせください）
・ページ数：117
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、放射線誘発骨髄抑制治療の世界市場について調べ、まとめました。種類別セグメントは、成長因子、エリスロポエチン刺激剤、血栓形成剤、鉄補給、その他等、用途別セグメントは、貧血、好中球減少症、血小板減少症、その他等に区分しました。放射線誘発骨髄抑制治療の世界市場概観、企業動向、企業別放射線誘発骨髄抑制治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・放射線誘発骨髄抑制治療の市場概観
・放射線誘発骨髄抑制治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・放射線誘発骨髄抑制治療の企業別販売動向、市場シェア、市場集中度、競争動向
・放射線誘発骨髄抑制治療の世界市場規模
・放射線誘発骨髄抑制治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・放射線誘発骨髄抑制治療のアメリカ市場規模推移
・放射線誘発骨髄抑制治療のカナダ市場規模推移
・放射線誘発骨髄抑制治療のメキシコ市場規模推移
・放射線誘発骨髄抑制治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・放射線誘発骨髄抑制治療のドイツ市場規模推移
・放射線誘発骨髄抑制治療のイギリス市場規模推移
・放射線誘発骨髄抑制治療のロシア市場規模推移
・放射線誘発骨髄抑制治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・放射線誘発骨髄抑制治療の日本市場規模推移
・放射線誘発骨髄抑制治療の中国市場規模推移
・放射線誘発骨髄抑制治療の韓国市場規模推移
・放射線誘発骨髄抑制治療のインド市場規模推移
・放射線誘発骨髄抑制治療の東南アジア市場規模推移
・放射線誘発骨髄抑制治療の南米市場分析（ブラジル、アルゼンチン等）
・放射線誘発骨髄抑制治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・放射線誘発骨髄抑制治療の種類別分析/販売量、売上、市場シェア（成長因子、エリスロポエチン刺激剤、血栓形成剤、鉄補給、その他）
・放射線誘発骨髄抑制治療の用途別分析/市場規模（貧血、好中球減少症、血小板減少症、その他）
・放射線誘発骨髄抑制治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・放射線誘発骨髄抑制治療の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Scope of the Report:
The global Radiation-Induced Myelosuppression Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Radiation-Induced Myelosuppression Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Radiation-Induced Myelosuppression Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Radiation-Induced Myelosuppression Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Johnson & Johnson
Novartis
Amgen
Teva Pharmaceutical
Mylan
Partner Therapeutics
Mission Pharmacal
Myelo Therapeutics
Pluristem Therapeutics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Growth Factors
Erythropoietin-stimulating Agents
Thrombopoietic Agents
Iron supplementation
Others

Market Segment by Applications, can be divided into
Anemia
Neutropenia
Thrombocytopenia
Others

【レポートの目次】

Table of Contents

1 Radiation-Induced Myelosuppression Treatment Market Overview
1.1 Product Overview and Scope of Radiation-Induced Myelosuppression Treatment
1.2 Classification of Radiation-Induced Myelosuppression Treatment by Types
1.2.1 Global Radiation-Induced Myelosuppression Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Radiation-Induced Myelosuppression Treatment Revenue Market Share by Types in 2018
1.2.3 Growth Factors
1.2.4 Erythropoietin-stimulating Agents
1.2.5 Thrombopoietic Agents
1.2.6 Iron supplementation
1.2.7 Others
1.3 Global Radiation-Induced Myelosuppression Treatment Market by Application
1.3.1 Global Radiation-Induced Myelosuppression Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Anemia
1.3.3 Neutropenia
1.3.4 Thrombocytopenia
1.3.5 Others
1.4 Global Radiation-Induced Myelosuppression Treatment Market by Regions
1.4.1 Global Radiation-Induced Myelosuppression Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Radiation-Induced Myelosuppression Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Radiation-Induced Myelosuppression Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Radiation-Induced Myelosuppression Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Radiation-Induced Myelosuppression Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Radiation-Induced Myelosuppression Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Radiation-Induced Myelosuppression Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Radiation-Induced Myelosuppression Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Radiation-Induced Myelosuppression Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Radiation-Induced Myelosuppression Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Radiation-Induced Myelosuppression Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teva Pharmaceutical
2.5.1 Business Overview
2.5.2 Radiation-Induced Myelosuppression Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Pharmaceutical Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Mylan
2.6.1 Business Overview
2.6.2 Radiation-Induced Myelosuppression Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Mylan Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Partner Therapeutics
2.7.1 Business Overview
2.7.2 Radiation-Induced Myelosuppression Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Partner Therapeutics Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Mission Pharmacal
2.8.1 Business Overview
2.8.2 Radiation-Induced Myelosuppression Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mission Pharmacal Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Myelo Therapeutics
2.9.1 Business Overview
2.9.2 Radiation-Induced Myelosuppression Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Myelo Therapeutics Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Pluristem Therapeutics
2.10.1 Business Overview
2.10.2 Radiation-Induced Myelosuppression Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pluristem Therapeutics Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Radiation-Induced Myelosuppression Treatment Market Competition, by Players
3.1 Global Radiation-Induced Myelosuppression Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Radiation-Induced Myelosuppression Treatment Players Market Share
3.2.2 Top 10 Radiation-Induced Myelosuppression Treatment Players Market Share
3.3 Market Competition Trend
4 Global Radiation-Induced Myelosuppression Treatment Market Size by Regions
4.1 Global Radiation-Induced Myelosuppression Treatment Revenue and Market Share by Regions
4.2 North America Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
5 North America Radiation-Induced Myelosuppression Treatment Revenue by Countries
5.1 North America Radiation-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
5.2 USA Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
6 Europe Radiation-Induced Myelosuppression Treatment Revenue by Countries
6.1 Europe Radiation-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
6.2 Germany Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
6.4 France Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Radiation-Induced Myelosuppression Treatment Revenue by Countries
7.1 Asia-Pacific Radiation-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
7.2 China Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
7.5 India Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
8 South America Radiation-Induced Myelosuppression Treatment Revenue by Countries
8.1 South America Radiation-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
8.2 Brazil Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Radiation-Induced Myelosuppression Treatment by Countries
9.1 Middle East and Africa Radiation-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
10 Global Radiation-Induced Myelosuppression Treatment Market Segment by Type
10.1 Global Radiation-Induced Myelosuppression Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Radiation-Induced Myelosuppression Treatment Market Forecast by Type (2019-2024)
10.3 Growth Factors Revenue Growth Rate (2014-2024)
10.4 Erythropoietin-stimulating Agents Revenue Growth Rate (2014-2024)
10.5 Thrombopoietic Agents Revenue Growth Rate (2014-2024)
10.6 Iron supplementation Revenue Growth Rate (2014-2024)
10.7 Others Revenue Growth Rate (2014-2024)
11 Global Radiation-Induced Myelosuppression Treatment Market Segment by Application
11.1 Global Radiation-Induced Myelosuppression Treatment Revenue Market Share by Application (2014-2019)
11.2 Radiation-Induced Myelosuppression Treatment Market Forecast by Application (2019-2024)
11.3 Anemia Revenue Growth (2014-2019)
11.4 Neutropenia Revenue Growth (2014-2019)
11.5 Thrombocytopenia Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Radiation-Induced Myelosuppression Treatment Market Size Forecast (2019-2024)
12.1 Global Radiation-Induced Myelosuppression Treatment Market Size Forecast (2019-2024)
12.2 Global Radiation-Induced Myelosuppression Treatment Market Forecast by Regions (2019-2024)
12.3 North America Radiation-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Radiation-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Radiation-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
12.6 South America Radiation-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Radiation-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Radiation-Induced Myelosuppression Treatment Picture
Table Product Specifications of Radiation-Induced Myelosuppression Treatment
Table Global Radiation-Induced Myelosuppression Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Radiation-Induced Myelosuppression Treatment Revenue Market Share by Types in 2018
Figure Growth Factors Picture
Figure Erythropoietin-stimulating Agents Picture
Figure Thrombopoietic Agents Picture
Figure Iron supplementation Picture
Figure Others Picture
Table Global Radiation-Induced Myelosuppression Treatment Revenue (Million USD) by Application (2014-2024)
Figure Radiation-Induced Myelosuppression Treatment Revenue Market Share by Applications in 2018
Figure Anemia Picture
Figure Neutropenia Picture
Figure Thrombocytopenia Picture
Figure Others Picture
Table Global Market Radiation-Induced Myelosuppression Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Radiation-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Radiation-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Radiation-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Radiation-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Radiation-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Radiation-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Radiation-Induced Myelosuppression Treatment Type and Applications
Table Pfizer Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Radiation-Induced Myelosuppression Treatment Type and Applications
Table Johnson & Johnson Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Radiation-Induced Myelosuppression Treatment Type and Applications
Table Novartis Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Radiation-Induced Myelosuppression Treatment Type and Applications
Table Amgen Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Radiation-Induced Myelosuppression Treatment Type and Applications
Table Teva Pharmaceutical Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Radiation-Induced Myelosuppression Treatment Type and Applications
Table Mylan Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Partner Therapeutics Basic Information, Manufacturing Base and Competitors
Table Partner Therapeutics Radiation-Induced Myelosuppression Treatment Type and Applications
Table Partner Therapeutics Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Mission Pharmacal Basic Information, Manufacturing Base and Competitors
Table Mission Pharmacal Radiation-Induced Myelosuppression Treatment Type and Applications
Table Mission Pharmacal Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Myelo Therapeutics Basic Information, Manufacturing Base and Competitors
Table Myelo Therapeutics Radiation-Induced Myelosuppression Treatment Type and Applications
Table Myelo Therapeutics Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Pluristem Therapeutics Basic Information, Manufacturing Base and Competitors
Table Pluristem Therapeutics Radiation-Induced Myelosuppression Treatment Type and Applications
Table Pluristem Therapeutics Radiation-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Radiation-Induced Myelosuppression Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Radiation-Induced Myelosuppression Treatment Revenue Share by Players (2014-2019)
Figure Global Radiation-Induced Myelosuppression Treatment Revenue Share by Players in 2017
Figure Global Radiation-Induced Myelosuppression Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Radiation-Induced Myelosuppression Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Radiation-Induced Myelosuppression Treatment Revenue Market Share in 2018
Figure Global Radiation-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Radiation-Induced Myelosuppression Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Radiation-Induced Myelosuppression Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Radiation-Induced Myelosuppression Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Radiation-Induced Myelosuppression Treatment Revenue Market Share by Regions in 2018
Figure North America Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure South America Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Table North America Radiation-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
Table North America Radiation-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Radiation-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Radiation-Induced Myelosuppression Treatment Revenue Market Share by Countries in 2018
Figure USA Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Table Europe Radiation-Induced Myelosuppression Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Radiation-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Radiation-Induced Myelosuppression Treatment Revenue Market Share by Countries in 2018
Figure Germany Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure UK Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure France Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Radiation-Induced Myelosuppression Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Radiation-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Radiation-Induced Myelosuppression Treatment Revenue Market Share by Countries in 2018
Figure China Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure India Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Table South America Radiation-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
Table South America Radiation-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Radiation-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Radiation-Induced Myelosuppression Treatment Revenue Market Share by Countries in 2018
Figure Brazil Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Radiation-Induced Myelosuppression Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Radiation-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Radiation-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Radiation-Induced Myelosuppression Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Radiation-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Table Global Radiation-Induced Myelosuppression Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Radiation-Induced Myelosuppression Treatment Revenue Share by Type (2014-2019)
Figure Global Radiation-Induced Myelosuppression Treatment Revenue Share by Type (2014-2019)
Figure Global Radiation-Induced Myelosuppression Treatment Revenue Share by Type in 2019
Table Global Radiation-Induced Myelosuppression Treatment Revenue Forecast by Type (2019-2024)
Figure Global Radiation-Induced Myelosuppression Treatment Market Share Forecast by Type (2019-2024)
Figure Global Growth Factors Revenue Growth Rate (2014-2019)
Figure Global Erythropoietin-stimulating Agents Revenue Growth Rate (2014-2019)
Figure Global Thrombopoietic Agents Revenue Growth Rate (2014-2019)
Figure Global Iron supplementation Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Radiation-Induced Myelosuppression Treatment Revenue by Application (2014-2019)
Table Global Radiation-Induced Myelosuppression Treatment Revenue Share by Application (2014-2019)
Figure Global Radiation-Induced Myelosuppression Treatment Revenue Share by Application (2014-2019)
Figure Global Radiation-Induced Myelosuppression Treatment Revenue Share by Application in 2019
Table Global Radiation-Induced Myelosuppression Treatment Revenue Forecast by Application (2019-2024)
Figure Global Radiation-Induced Myelosuppression Treatment Market Share Forecast by Application (2019-2024)
Figure Global Anemia Revenue Growth Rate (2014-2019)
Figure Global Neutropenia Revenue Growth Rate (2014-2019)
Figure Global Thrombocytopenia Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Radiation-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Radiation-Induced Myelosuppression Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Radiation-Induced Myelosuppression Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Radiation-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
Figure Europe Radiation-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Radiation-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
Figure South America Radiation-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Radiation-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)


【掲載企業】

Pfizer、Johnson & Johnson、Novartis、Amgen、Teva Pharmaceutical、Mylan、Partner Therapeutics、Mission Pharmacal、Myelo Therapeutics、Pluristem Therapeutics、

★調査レポート[放射線誘発骨髄抑制治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9103354)販売に関する免責事項を必ずご確認ください。
★調査レポート[放射線誘発骨髄抑制治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 化学療法による骨髄抑制治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102889 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、化学療法による骨髄抑制治療の世界市場について調べ、まとめました。種類別セグメントは、経口、注射剤等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。化学療法による骨髄抑制治療の世界市場概観、企業動向、企業別化学療法による骨髄抑制治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・化学療法による骨髄抑制治療の市場概観 ・化学療法による骨髄抑制治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・化学療法による骨髄抑制治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・化学療法による骨髄抑制治療の世界市場規模 ・化学療法による骨髄抑制治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・化学療法による骨髄抑制治療のアメリカ市場規模推移 ・化学療法による骨髄抑制治療のカナダ市場規模推移 ・化学療法による骨髄抑制治療のメキシコ市場規模推移 ・化学療法による骨髄抑制治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Chemotherapy-Induced Myelosuppression Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chemotherapy-Induced Myelosuppression Treatment. Europe also play important roles in...
  • 人工多能性幹細胞（iPSC）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103577 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、人工多能性幹細胞（iPSC）の世界市場について調べ、まとめました。種類別セグメントは、ヒトiPSC、マウスiPSC等、用途別セグメントは、学術研究、医薬品の開発と発見、毒性スクリーニング、再生医学等に区分しました。人工多能性幹細胞（iPSC）の世界市場概観、企業動向、企業別人工多能性幹細胞（iPSC）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・人工多能性幹細胞（iPSC）の市場概観 ・人工多能性幹細胞（iPSC）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・人工多能性幹細胞（iPSC）の企業別販売動向、市場シェア、市場集中度、競争動向 ・人工多能性幹細胞（iPSC）の世界市場規模 ・人工多能性幹細胞（iPSC）の北米市場分析（アメリカ、カナダ、メキシコ等） ・人工多能性幹細胞（iPSC）のアメリカ市場規模推移 ・人工多能性幹細胞（iPSC）のカナダ市場規模推移 ・人工多能性幹細胞（iPSC）のメキシコ市場規模推移 ・人工多能性幹細胞（iPSC）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Description Scope of the Report: The global Induced Pluripotent Stem Cells (iPSCs) market is valued at 74 million USD in 2018 and is expected to reach 114.9 million USD by the end of 2024, growing at a CAGR of 11.7% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Induced Pluripotent Stem Cells (iPSCs). Europe also...
  • モバイル放射線シールドの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102805 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、モバイル放射線シールドの世界市場について調べ、まとめました。種類別セグメントは、ウィンドウなし、ウィンドウあり等、用途別セグメントは、病院、治療センター、その他等に区分しました。モバイル放射線シールドの世界市場概観、メーカー動向、メーカー別モバイル放射線シールドシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・モバイル放射線シールドの市場概観 ・モバイル放射線シールドの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・モバイル放射線シールドの企業別販売動向、市場シェア、市場集中度、競争動向 ・モバイル放射線シールドの世界市場規模 ・モバイル放射線シールドの北米市場分析（アメリカ、カナダ、メキシコ等） ・モバイル放射線シールドのアメリカ市場規模推移 ・モバイル放射線シールドのカナダ市場規模推移 ・モバイル放射線シールドのメキシコ市場規模推移 ・モバイル放射線シールドのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Mobile Radiation Shield is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Mobile Radiation Shield in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers MAVIG  BIODEX Bright Technologies Cablas Capintec MarShield Comecer...
  • 放射線処理の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101799 / GlobalInfoResearch / 2019年9月13日 / 本調査レポートは、放射線処理の世界市場について調べ、まとめました。種類別セグメントは、放射性同位元素、電子加速器等、用途別セグメントは、医療・食品産業、産業、科学研究、その他等に区分しました。放射線処理の世界市場概観、企業動向、企業別放射線処理シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・放射線処理の市場概観 ・放射線処理の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・放射線処理の企業別販売動向、市場シェア、市場集中度、競争動向 ・放射線処理の世界市場規模 ・放射線処理の北米市場分析（アメリカ、カナダ、メキシコ等） ・放射線処理のアメリカ市場規模推移 ・放射線処理のカナダ市場規模推移 ・放射線処理のメキシコ市場規模推移 ・放射線処理のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Radiation Processing is widely used for industrial applications such as surface curing, crosslinking of wires and cables and sterilization/ decontamination of pharmaceutical products. The energy of the electron beam determines the type of applications. This is due to the penetration power of the electron that is limited by the energy. Scope of the Report: A variety of sources are available for material modification, such as high intensity radioisotope sources, electron accelerators of various energies, and the X-rays they produce. Irradiation can also be used for grafting. Radiation processing technology has received more and more attention in protecting the environment, such...
  • 化学セクターにおける放射線処理の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101800 / GlobalInfoResearch / 2019年9月13日 / 本調査レポートは、化学セクターにおける放射線処理の世界市場について調べ、まとめました。種類別セグメントは、放射性同位元素、電子加速器等、用途別セグメントは、ワイヤーとケーブル、発泡ポリオレフィン、ゴム、その他等に区分しました。化学セクターにおける放射線処理の世界市場概観、企業動向、企業別化学セクターにおける放射線処理シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・化学セクターにおける放射線処理の市場概観 ・化学セクターにおける放射線処理の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・化学セクターにおける放射線処理の企業別販売動向、市場シェア、市場集中度、競争動向 ・化学セクターにおける放射線処理の世界市場規模 ・化学セクターにおける放射線処理の北米市場分析（アメリカ、カナダ、メキシコ等） ・化学セクターにおける放射線処理のアメリカ市場規模推移 ・化学セクターにおける放射線処理のカナダ市場規模推移 ・化学セクターにおける放射線処理のメキシコ市場規模推移 ・化学セクターにおける放射線処理のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Radiation Processing is widely used for industrial applications such as surface curing, crosslinking of wires and cables and sterilization/ decontamination of pharmaceutical products. The energy of the electron beam determines the type of applications. This is due to the penetration power of the electron that is limited by the energy. Scope of the Report: A variety of sources are available for material modification, such as high intensity radioisotope sources, electron accelerators of various energies, and the X-rays they produce. Irradiation can also be used for grafting. Radiation processing technology has received more and more attention in protecting the environment, such...

    • ◆H&Iグローバルリサーチのお客様（例）◆